• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铁死亡与肿瘤微环境。

Ferroptosis and the tumor microenvironment.

机构信息

Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Huihe Road 200, Wuxi, Jiangsu, 214062, China.

Laboratory of Cancer Epigenetics, Wuxi School of Medicine, Jiangnan University, Lihu Avenue 1800, Wuxi, Jiangsu, 214122, China.

出版信息

J Exp Clin Cancer Res. 2024 Nov 30;43(1):315. doi: 10.1186/s13046-024-03235-0.

DOI:10.1186/s13046-024-03235-0
PMID:39614322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11607824/
Abstract

Ferroptosis is a type of regulated cell death characterized by its non-apoptotic, iron-dependent and oxidative nature. Since its discovery in 2012, extensive research has demonstrated its pivotal roles in tumorigenesis, metastasis and cancer therapy. The tumor microenvironment (TME) is a complex ecosystem comprising cancer cells, non-cancer cells, extracellular matrix, metabolites and cytokines. Recent studies have underscored a new paradigm in which non-cancer cells in the TME, such as immune and stromal cells, also play significant roles in regulating tumor progression and therapeutic resistance typically through complicated crosstalk with cancer cells. Notably, this crosstalk in the TME were partially mediated through ferrotopsis-related mechanisms. This review provides a comprehensive and systematic summary of the current findings concerning the roles of ferroptosis in the TME and how ferroptosis-mediated TME reprogramming impacts cancer therapeutic resistance and progression. Additionally, this review outlines various ferroptosis-related therapeutic strategies aimed at targeting the TME.

摘要

铁死亡是一种受调控的细胞死亡方式,其特征是非凋亡、铁依赖性和氧化性质。自 2012 年发现以来,广泛的研究表明它在肿瘤发生、转移和癌症治疗中具有关键作用。肿瘤微环境(TME)是一个复杂的生态系统,包括癌细胞、非癌细胞、细胞外基质、代谢物和细胞因子。最近的研究强调了一种新的模式,即 TME 中的非癌细胞,如免疫和基质细胞,也通过与癌细胞的复杂相互作用,在调节肿瘤进展和治疗耐药性方面发挥重要作用。值得注意的是,这种 TME 中的串扰部分是通过铁死亡相关机制介导的。本综述全面系统地总结了铁死亡在 TME 中的作用以及铁死亡介导的 TME 重编程如何影响癌症治疗耐药性和进展的最新发现。此外,本综述还概述了各种针对 TME 的铁死亡相关治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/de35a0d1e09d/13046_2024_3235_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/c7a3e94e1bc0/13046_2024_3235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/fea07f6c1bad/13046_2024_3235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/ba10e1589647/13046_2024_3235_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/de35a0d1e09d/13046_2024_3235_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/c7a3e94e1bc0/13046_2024_3235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/fea07f6c1bad/13046_2024_3235_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/ba10e1589647/13046_2024_3235_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eac/11607824/de35a0d1e09d/13046_2024_3235_Fig4_HTML.jpg

相似文献

1
Ferroptosis and the tumor microenvironment.铁死亡与肿瘤微环境。
J Exp Clin Cancer Res. 2024 Nov 30;43(1):315. doi: 10.1186/s13046-024-03235-0.
2
Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment.铁死亡与肿瘤免疫:从肿瘤微环境中主要细胞成分的角度看。
Eur J Pharmacol. 2023 Dec 15;961:176124. doi: 10.1016/j.ejphar.2023.176124. Epub 2023 Nov 3.
3
Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy.整合单细胞转录组学揭示肿瘤微环境中的铁死亡调控因子,促进膀胱癌尿路上皮癌进展和免疫治疗。
Front Immunol. 2024 Aug 22;15:1427124. doi: 10.3389/fimmu.2024.1427124. eCollection 2024.
4
Ferroptosis-mediated Crosstalk in the Tumor Microenvironment Implicated in Cancer Progression and Therapy.铁死亡介导的肿瘤微环境中的串扰与癌症进展和治疗相关
Front Cell Dev Biol. 2021 Nov 2;9:739392. doi: 10.3389/fcell.2021.739392. eCollection 2021.
5
Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.肿瘤微环境中癌症相关成纤维细胞和免疫细胞的代谢重编程及串扰。
Front Endocrinol (Lausanne). 2022 Aug 15;13:988295. doi: 10.3389/fendo.2022.988295. eCollection 2022.
6
Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.代谢重编程、自噬和铁死亡:克服胃肠道癌症免疫治疗耐药性的新武器。
Cancer Med. 2023 Nov;12(21):20573-20589. doi: 10.1002/cam4.6623. Epub 2023 Oct 20.
7
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects.铁死亡在抗肿瘤免疫治疗中的串扰:分子机制、肿瘤微环境、应用前景。
Apoptosis. 2024 Dec;29(11-12):1914-1943. doi: 10.1007/s10495-024-01997-8. Epub 2024 Jul 15.
8
The crosstalk of CD8+ T cells and ferroptosis in cancer.CD8+ T 细胞与肿瘤中铁死亡的串扰。
Front Immunol. 2024 Jan 15;14:1255443. doi: 10.3389/fimmu.2023.1255443. eCollection 2023.
9
Ferroptosis in the tumor microenvironment: perspectives for immunotherapy.肿瘤微环境中的铁死亡:免疫治疗的新视角。
Trends Mol Med. 2021 Sep;27(9):856-867. doi: 10.1016/j.molmed.2021.06.014. Epub 2021 Jul 23.
10
The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.铁死亡分子亚型揭示了胃癌肿瘤微环境、免疫治疗反应和预后的特征。
Int J Mol Sci. 2022 Aug 29;23(17):9767. doi: 10.3390/ijms23179767.

引用本文的文献

1
RAB22A triggers intercellular chemoresistance transmission in colorectal cancer by promoting exosome release via the PKM2-pSNAP23 axis.RAB22A通过PKM2-pSNAP23轴促进外泌体释放,从而引发结直肠癌的细胞间化疗耐药性传递。
Oncogene. 2025 Sep 16. doi: 10.1038/s41388-025-03566-y.
2
FK228 reshapes tumor microenvironment to enhance anti-PD-L1 efficacy.FK228重塑肿瘤微环境以增强抗PD-L1疗效。
Oncogene. 2025 Sep 12. doi: 10.1038/s41388-025-03558-y.
3
Cancer-associated fibroblast-mediated immune evasion: molecular mechanisms of stromal-immune crosstalk in the tumor microenvironment.

本文引用的文献

1
Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors.靶向 GPX4 介导的铁死亡保护使 BRCA1 缺陷型癌细胞对 PARP 抑制剂敏感。
Redox Biol. 2024 Oct;76:103350. doi: 10.1016/j.redox.2024.103350. Epub 2024 Sep 11.
2
Phospholipid peroxidation in macrophage confers tumor resistance by suppressing phagocytic capability towards ferroptotic cells.巨噬细胞中的磷脂过氧化作用通过抑制对铁死亡细胞的吞噬能力赋予肿瘤抗性。
Cell Death Differ. 2024 Sep;31(9):1184-1201. doi: 10.1038/s41418-024-01351-0. Epub 2024 Aug 5.
3
LACTB suppresses liver cancer progression through regulation of ferroptosis.
癌症相关成纤维细胞介导的免疫逃逸:肿瘤微环境中基质 - 免疫相互作用的分子机制
Front Immunol. 2025 Aug 26;16:1617662. doi: 10.3389/fimmu.2025.1617662. eCollection 2025.
4
Ferroptosis in the tumor microenvironment: mechanisms, advances, and therapeutic perspectives.肿瘤微环境中的铁死亡:机制、进展与治疗前景
Front Oncol. 2025 Aug 22;15:1650219. doi: 10.3389/fonc.2025.1650219. eCollection 2025.
5
Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications.宫颈癌中的铁死亡-免疫相互作用:机制及治疗意义
Front Immunol. 2025 Aug 15;16:1657905. doi: 10.3389/fimmu.2025.1657905. eCollection 2025.
6
Radionuclide-labeled nanomaterials for tumor therapy: Recent progress and perspectives.用于肿瘤治疗的放射性核素标记纳米材料:最新进展与展望
Mater Today Bio. 2025 Aug 5;34:102156. doi: 10.1016/j.mtbio.2025.102156. eCollection 2025 Oct.
7
Cancer-associated fibroblasts: dual roles from senescence sentinels to death regulators and new dimensions in therapy.癌症相关成纤维细胞:从衰老哨兵到死亡调节因子的双重作用及治疗新维度
Front Immunol. 2025 Jul 18;16:1635771. doi: 10.3389/fimmu.2025.1635771. eCollection 2025.
8
Targeting ribosomes reprograms the tumour microenvironment and augments cancer immunotherapy.靶向核糖体可重编程肿瘤微环境并增强癌症免疫疗法。
Br J Cancer. 2025 Jul 11. doi: 10.1038/s41416-025-03109-y.
9
Identification of ferroptosis related genes and subtypes in colorectal cancer.结直肠癌中铁死亡相关基因及亚型的鉴定
Sci Rep. 2025 Jul 2;15(1):22717. doi: 10.1038/s41598-025-08901-7.
10
OTUB1 promotes colorectal cancer progression by stabilizing GPX4 and inhibiting ferroptosis.OTUB1通过稳定GPX4并抑制铁死亡来促进结直肠癌进展。
Discov Oncol. 2025 Jul 1;16(1):1240. doi: 10.1007/s12672-025-03022-z.
LACTB 通过调控铁死亡抑制肝癌进展。
Redox Biol. 2024 Sep;75:103270. doi: 10.1016/j.redox.2024.103270. Epub 2024 Jul 18.
4
Ferroptosis: principles and significance in health and disease.铁死亡:在健康和疾病中的原理和意义。
J Hematol Oncol. 2024 Jun 6;17(1):41. doi: 10.1186/s13045-024-01564-3.
5
BIBR1532 combined with radiotherapy induces ferroptosis in NSCLC cells and activates cGAS-STING pathway to promote anti-tumor immunity.BIBR1532 联合放射治疗诱导非小细胞肺癌细胞发生铁死亡,并激活 cGAS-STING 通路促进抗肿瘤免疫。
J Transl Med. 2024 May 30;22(1):519. doi: 10.1186/s12967-024-05331-3.
6
Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?铁死亡和铜死亡:经典化疗药物激活的依赖金属的细胞死亡途径——对癌症治疗的意义?
Biochim Biophys Acta Rev Cancer. 2024 Jul;1879(4):189124. doi: 10.1016/j.bbcan.2024.189124. Epub 2024 May 25.
7
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.对LIF/LIFR自分泌环的药理学抑制揭示了卵巢癌细胞对铁死亡的易感性。
NPJ Precis Oncol. 2024 May 24;8(1):118. doi: 10.1038/s41698-024-00612-y.
8
A platinum(IV)-artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy.一种铂(IV)-青蒿琥酯复合物通过促进细胞质和线粒体脂质过氧化来触发铁死亡,从而增强肿瘤免疫治疗。
MedComm (2020). 2024 May 20;5(6):e570. doi: 10.1002/mco2.570. eCollection 2024 Jun.
9
Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer.癌症相关成纤维细胞分泌的miR-432-5p靶向CHAC1以抑制铁死亡并促进前列腺癌的获得性化疗耐药。
Oncogene. 2024 Jun;43(27):2104-2114. doi: 10.1038/s41388-024-03057-6. Epub 2024 May 20.
10
DEPDC5 protects CD8 T cells from ferroptosis by limiting mTORC1-mediated purine catabolism.DEPDC5通过限制mTORC1介导的嘌呤分解代谢来保护CD8 T细胞免受铁死亡。
Cell Discov. 2024 May 20;10(1):53. doi: 10.1038/s41421-024-00682-z.